Jared Weiss
Impact in
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 12
- Cancer survivorship and care 2
- Colorectal Cancer Surgical Treatments 2
- CAR-T cell therapy research 2
-
- Head and Neck Cancer Studies 4
- Co-authors
- Tanguy Y. Seiwert (5 shared papers)Jonathan D. Cheng (4 shared papers)Barbara Ann Burtness (3 shared papers)Laura Q.M. Chow (3 shared papers)Joseph P. Eder (3 shared papers)Ranee Mehra (3 shared papers)Jared K. Lunceford (2 shared papers)Terrill K. McClanahan (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (4 papers)Journal of Clinical Oncology (3 papers)New England Journal of Medicine (2 papers)Clinical Colorectal Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Jared Weiss
27 papers receiving 4.9k citations
Jared Weiss's Hit Papers
Peers
Comparison fields: 5 of 80
- Otorhinolaryngology 1.4k
- Oncology 2.7k
- Endocrinology, Diabetes and Metabolism 421
- Cancer Research 183
- Pulmonary and Respiratory Medicine 387
Countries citing papers authored by Jared Weiss
This map shows the geographic impact of Jared Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared Weiss more than expected).
Fields of papers citing papers by Jared Weiss
This network shows the impact of papers produced by Jared Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared Weiss. The network helps show where Jared Weiss may publish in the future.
Co-authors
The 25 scholars most cited alongside Jared Weiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial Hit paper breakdown → | 2016 | 1449 |
| 2 | Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort Hit paper breakdown → | 2016 | 720 |
| 3 | Efficacy of Selpercatinib in RET -Altered Thyroid Cancers Hit paper breakdown → | 2020 | 593 |
| 4 | Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study Hit paper breakdown → | 2017 | 562 |
| 5 | Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C Hit paper breakdown → | 2022 | 379 |
| 6 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012 Hit paper breakdown → | 2018 | 372 |
| 7 | 2022 | 89 | |
| 8 | 2022 | 76 | |
| 9 | 2019 | 74 | |
| 10 | 2020 | 74 | |
| 11 | 2020 | 70 | |
| 12 | 2022 | 66 | |
| 13 | 2023 | 59 | |
| 14 | 2021 | 56 | |
| 15 | 2019 | 49 | |
| 16 | 2009 | 40 | |
| 17 | 2016 | 40 | |
| 18 | 2024 | 34 | |
| 19 | 2013 | 32 | |
| 20 | 2022 | 28 |
About Jared Weiss
Jared Weiss is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Pharmacology and Dermatology, having authored 28 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer survivorship and care (2 papers), Drug-Induced Adverse Reactions (2 papers), Colorectal Cancer Surgical Treatments (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Otorhinolaryngology (1.4k citations), Oncology (2.7k citations), Endocrinology, Diabetes and Metabolism (421 citations), Cancer Research (183 citations) and Pulmonary and Respiratory Medicine (387 citations). Jared Weiss has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Tanguy Y. Seiwert, Jonathan D. Cheng, Barbara Ann Burtness, Laura Q.M. Chow, Joseph P. Eder, Ranee Mehra, Jared K. Lunceford, Terrill K. McClanahan, Christine K. Gause and Karl Heath. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, New England Journal of Medicine, Clinical Colorectal Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.